Inhibikase Therapeutics Inc

NASDAQ:IKT  
5.74
+0.61 (+11.89%)
Equity Financing / Related, Initial Public Offerings

Inhibikase Therapeutics Says Offering 2.3 Mln Shares In IPO

Published: 09/15/2020 22:41 GMT
Inhibikase Therapeutics Inc (IKT) - Inhibikase Therapeutics Says Offering 2.3 Million Shares of Our Common Stock in Ipo.
Inhibikase Therapeutics - Anticipate Ipo Price of Shares Will Be Between $10.00 & $12.00 per Share.